Navigation Links
Women Health Expert GC-Rise Launches Obstetrician-gynecologist Prize
Date:7/31/2012

BEIJING, July 31, 2012 /PRNewswire-Asia/ -- GC-Rise Pharmaceutical Co. Ltd, in which European healthcare venture capital firm INVENTAGES holds a majority stake, has launched an obstetrician-gynecologist Honorary Award given to those who have done outstanding achievement in the medical community.

The company on July 15 held the first-ever GC-Rise-Cup ceremony in Hefei, capital city of central China's Anhui province, where awards were presented to 20 obstetrician-gynecologists chosen from around the country.

The 20 final award-winners stood out among 70 candidates after six months' open and fair appraisals by the selection committee.

The winners, with an average age of 80, include the expert who did the first test-tube baby in China, the doctor who was the first to advocate the importance of maternal and infant care and the one who was the first to promote the idea of painless delivery.

The prize, which compares to the 'OSCAR' in the medical industry, was jointly initiated by GC-Rise and China Medical Doctor Association, and is the first-ever and only award pointing to individuals in the medical circle in China.

The move aims to encourage the younger generations to inherit the spirits of the seniors, which shows GC-Rise's consistent commitment to play an active part in the women's health industry by joining hands with experts and professionals in the circle.

About GC-Rise Pharmaceutical Co. Ltd

GC-Rise Pharmaceutical Co. Ltd, established in 2008, is a wholly-owned foreign enterprise invested by INVENTAGES, a major European healthcare and biotechnology venture capital investor, focuses on women's health. Taking "Devoted to human healthcare and a better life" as our mission, the company makes full use of the business networks of our strategic partners in the United States, Europe and Japan, their rich experiences in clinical development, clinical trials and registration in China and their strong strength in distributions, hospital sales and marketing, so as to provide safe, novel and highly efficient medical products and treatment ideas for Chinese women patients.

Please log on http://www.gc-rise.com/ to know more information.



'/>"/>
SOURCE GC-Rise Pharmaceutical Co. Ltd
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Publication of PrEP Trial Data Provides Clear Evidence that PrEP Works for Men and Women
2. Relief from Menopause Symptoms Short-lived for Prempro Women Suffering from Cancers
3. What 20% of Women Want and Only 1% Get
4. IntelligentMDx Announces CE-Marking of a new high-throughput test for Group B Streptococcus intended to improve womens health and prenatal care
5. Viztek Announces Availability of Opal-Mammo Integrated Mammography Suite - Complete Womens Health Package Combines PACS and Tracking Software
6. New Reproductive Support Dietary Supplement, Pregnitude™, Now Available For Women Having Difficulty Conceiving
7. Bayer Employees Named Rising Stars by Healthcare Businesswomens Association
8. Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women
9. Nouveau Life Pharmaceuticals (NOUV) Releases Krill Oil to Support Healthy Cholesterol Levels and Reduce Inflammation
10. Concordia Study Indicates Obesity is Becoming the Nations Top Health Issue
11. Radiation Control Technologies, Inc. Announces Exclusive License to Two Patents from the National Institutes of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... MUMBAI , March 23, 2017 ... de Piramal Enterprises Limited, anuncia el nombramiento de ... PPS ofrece una plataforma de servicios integrados completa ... Needleman desempeñará un cargo clave en el crecimiento ... comercial, Needleman será responsable de impulsar todas las ...
(Date:3/23/2017)... 23, 2017  Galmed Pharmaceuticals Ltd. (Nasdaq: ... clinical-stage biopharmaceutical company focused on the development of ... nonalcoholic steatohepatitis, or NASH, and other liver diseases, ... twelve months ended December 31, 2016, and announced new ... demonstrating Aramchol™,s potential direct effect on liver fibrosis. ...
(Date:3/23/2017)... 23, 2017 ReNeuron reported in December ... in chronic stroke patients, despite not meeting the three-month time ... the Action Research Arm Test (ARAT). As a result, the ... controlled clinical study in 2017. Beyond CTX, we expect safety ... 2017 and Phase I data from its critical limb ischaemia ...
Breaking Medicine Technology:
(Date:3/23/2017)... Yardley, PA (PRWEB) , ... March 23, 2017 ... ... received Patient Oriented Disease Management Accreditation from the NCQA. The accreditation covers StayWell’s ... programs. , Accredited status is granted to organizations that have excellent programs ...
(Date:3/23/2017)... ... , ... The TouchPoint Solution, home of Buzzies *, is boosting the ... , “Buzzies change the way we interact with stress and live our day-to-day lives,” ... date in December 2016, The TouchPoint Solution has sold more than $750,000 in product ...
(Date:3/23/2017)... , ... March 23, 2017 , ... After raising more ... FaceCradle , the most-funded travel pillow in crowdfunding history, has established a ... its wildly popular travel innovation to Americans. , “We’re excited to be operating on ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... today announced rapid completion of the strategic executive team expansion needed to further ... to the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
Breaking Medicine News(10 mins):